135 related articles for article (PubMed ID: 23085259)
1. DNA methylation: new therapeutic implications for hepatic fibrosis.
Bian EB; Huang C; Wang H; Wu BM; Zhang L; Lv XW; Li J
Cell Signal; 2013 Jan; 25(1):355-8. PubMed ID: 23085259
[TBL] [Abstract][Full Text] [Related]
2. The potential of microRNAs in liver fibrosis.
He Y; Huang C; Zhang SP; Sun X; Long XR; Li J
Cell Signal; 2012 Dec; 24(12):2268-72. PubMed ID: 22884954
[TBL] [Abstract][Full Text] [Related]
3. Indole-3-carbinol enhances the resolution of rat liver fibrosis and stimulates hepatic stellate cell apoptosis by blocking the inhibitor of κB kinase α/inhibitor of κB-α/nuclear factor-κB pathway.
Ping J; Gao AM; Qin HQ; Wei XN; Bai J; Liu L; Li XH; Li RW; Ao Y; Wang H
J Pharmacol Exp Ther; 2011 Nov; 339(2):694-703. PubMed ID: 21862660
[TBL] [Abstract][Full Text] [Related]
4. New advances of DNA methylation in liver fibrosis, with special emphasis on the crosstalk between microRNAs and DNA methylation machinery.
Bian EB; Zhao B; Huang C; Wang H; Meng XM; Wu BM; Ma TT; Zhang L; Lv XW; Li J
Cell Signal; 2013 Sep; 25(9):1837-44. PubMed ID: 23707524
[TBL] [Abstract][Full Text] [Related]
5. Methylation of Septin9 mediated by DNMT3a enhances hepatic stellate cells activation and liver fibrogenesis.
Wu Y; Bu F; Yu H; Li W; Huang C; Meng X; Zhang L; Ma T; Li J
Toxicol Appl Pharmacol; 2017 Jan; 315():35-49. PubMed ID: 27939986
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of hepatic stellate cell activation and liver fibrosis.
El Taghdouini A; van Grunsven LA
Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1397-1408. PubMed ID: 27762150
[TBL] [Abstract][Full Text] [Related]
7. New advances of DNA/RNA methylation modification in liver fibrosis.
Yang L; Liu Y; Sun Y; Huang C; Li J; Wang Y
Cell Signal; 2022 Apr; 92():110224. PubMed ID: 34954394
[TBL] [Abstract][Full Text] [Related]
8. DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats.
Bian EB; Huang C; Ma TT; Tao H; Zhang H; Cheng C; Lv XW; Li J
Toxicol Appl Pharmacol; 2012 Oct; 264(1):13-22. PubMed ID: 22841775
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modifications in hepatic stellate cells contribute to liver fibrosis.
Zhao Q; Qin CY; Zhao ZH; Fan YC; Wang K
Tohoku J Exp Med; 2013 Jan; 229(1):35-43. PubMed ID: 23238615
[TBL] [Abstract][Full Text] [Related]
10. Clearance of activated stellate cells for hepatic fibrosis regression: molecular basis and translational potential.
Kong D; Zhang F; Zhang Z; Lu Y; Zheng S
Biomed Pharmacother; 2013 Apr; 67(3):246-50. PubMed ID: 23201010
[TBL] [Abstract][Full Text] [Related]
11. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis.
Wang Y; Gao J; Zhang D; Zhang J; Ma J; Jiang H
J Hepatol; 2010 Jul; 53(1):132-44. PubMed ID: 20447716
[TBL] [Abstract][Full Text] [Related]
12. Salvianolic acid B-induced microRNA-152 inhibits liver fibrosis by attenuating DNMT1-mediated Patched1 methylation.
Yu F; Lu Z; Chen B; Wu X; Dong P; Zheng J
J Cell Mol Med; 2015 Nov; 19(11):2617-32. PubMed ID: 26257392
[TBL] [Abstract][Full Text] [Related]
13. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
Carloni V; Luong TV; Rombouts K
Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of MAPK and NF-κB signaling pathways alleviate carbon tetrachloride (CCl4)-induced liver fibrosis in Toll-like receptor 5 (TLR5) deficiency mice.
Shu M; Huang DD; Hung ZA; Hu XR; Zhang S
Biochem Biophys Res Commun; 2016 Feb; 471(1):233-9. PubMed ID: 26845355
[TBL] [Abstract][Full Text] [Related]
15. CREB family: A significant role in liver fibrosis.
Li G; Jiang Q; Xu K
Biochimie; 2019 Aug; 163():94-100. PubMed ID: 31112743
[TBL] [Abstract][Full Text] [Related]
16. Caffeic acid phenethyl ester attenuates pro-inflammatory and fibrogenic phenotypes of LPS-stimulated hepatic stellate cells through the inhibition of NF-κB signaling.
Zhao WX; Wang L; Yang JL; Li LZ; Xu WM; Li T
Int J Mol Med; 2014 Mar; 33(3):687-94. PubMed ID: 24378685
[TBL] [Abstract][Full Text] [Related]
17. Hedgehog signaling pathway as key player in liver fibrosis: new insights and perspectives.
Yang JJ; Tao H; Li J
Expert Opin Ther Targets; 2014 Sep; 18(9):1011-21. PubMed ID: 24935558
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Mechanisms in Hepatic Stellate Cell Activation During Liver Fibrosis and Carcinogenesis.
Barcena-Varela M; Colyn L; Fernandez-Barrena MG
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117267
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-κB pathway.
Feng X; Tan W; Cheng S; Wang H; Ye S; Yu C; He Y; Zeng J; Cen J; Hu J; Zheng R; Zhou Y
DNA Cell Biol; 2015 Jul; 34(7):470-80. PubMed ID: 25974152
[TBL] [Abstract][Full Text] [Related]
20. Clinical Advancements in the Targeted Therapies against Liver Fibrosis.
Bansal R; Nagórniewicz B; Prakash J
Mediators Inflamm; 2016; 2016():7629724. PubMed ID: 27999454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
